Skip to main content
NIH funding notice RFA-AR-20-002

Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

Closed on December 1, 2020.

Posted
April 25, 2019
Close date
December 1, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $547,004 in first-year total cost, median $273,502.

Most frequent study sections

  1. Special Emphasis Panel[ZAR1 FY (M1)]2

Most frequent institutions

  1. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  2. UNIVERSITY OF VERMONT & ST AGRIC COLLEGE1
Competing awards under RFA-AR-20-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Immunomonitoring and Microbiome Analysis in Alopecia Areata Patients Undergoing Fecal Microbiota Transplantation1R21AR076764-01A1CHRISTIANO, ANGELA MCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$285,120ZAR1
2021Biomechanical Markers of PTOA after ACL Reconstruction and Meniscal Resection1R21AR077371-01A1FIORENTINO, NICCOLO MUNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT$261,884ZAR1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AR-20-002: Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience